Overexpression of HIF‐1α and HIF‐2α leads to the upregulation of genes involved in proliferation, angiogenesis, and glucose metabolism, and is associated with tumor progression in several cancers including RCC (Gordan et al., 2008; Rankin and Giaccia, 2008). This evidence concerns the gene EPAS1 and renal cell carcinoma.